Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jun 2023 for Checkpoint Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Scott Boilen: trading record in brief
Scott Boilen (board member) discloses dealings in Checkpoint Therapeutics, Inc. to SEC (Form 4). Between 10 June 2021 and 13 June 2023, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 15 June 2023: a share grant, in Checkpoint Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Scott Boilen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
17,483 shares0COMMON STOCKSEC:0001104659-23-071757:0
47,619 shares0COMMON STOCKSEC:0001104659-22-074468:0
16,502 shares0COMMON STOCKSEC:0001104659-21-080365:0
3 of 3 declarations
